
|Videos|February 17, 2023
Cardiovascular Disease Risk in Men with Prostate Cancer
Expert perspectives on the risk of cardiovascular disease as it exists in the context of androgen deprivation therapy (ADT) and prostate cancer.
Advertisement
Episodes in this series

Now Playing
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
2
Experts discuss the challenge of detecting CIS in bladder cancer
3
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
4
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
5



















